⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVS News
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026
globenewswire.com
CRVS
Three-Year Real-World Study Compares Burosumab Treatment with Oral Phosphate and Active Vitamin D in Adults with XLH
globenewswire.com
CRVS
RARE
T-Cell Malignancies (CTCL and PTCL) - 7MM Market Insights, Epidemiology, and Forecast - 2036 | Market to Reach USD 3.17 Billion as Targeted Therapies Advance
globenewswire.com
BIIB
PFE
TSEM
CRVS
AUTL
SLGN
Talawar Therapeutics Appoints Industry Veterans Mittie Doyle, MD, and Susannah Gray to Board of Directors
prnewswire.com
CRVS
SANA
LLY
MRVI
FDMT
ANAB
ZYME
Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
globenewswire.com
CRVS
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
globenewswire.com
CRVS
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
globenewswire.com
CRVS
Form 8-K
sec.gov
CRVS
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results
globenewswire.com
CRVS
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results
globenewswire.com
CRVS